Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
923.65
5.75 (0.63%)
< Home < Back

NATCO Pharma informs about press release

Date: 18-04-2024

NATCO Pharma has informed that it enclosed the Press Release and disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

The above information is a part of company’s filings submitted to BSE.